8m agoGuruFocusBULLISH 63Analyst
Why Is EXELIXIS INC (EXEL) Stock Up Today?
By the Top Tier Newswire AI Desk · reviewed against 16 wire stories
EXELIXIS INC (EXEL) is up +8.14% in the latest session. Our newswire has captured 16 stories on EXEL across 7 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
The written analysis for EXEL publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.
EXEL by the numbers
Last: $71.59Session: +8.14%7 sessions: +1.82%Coverage: 16 stories / 7 sourcesAI sentiment: 60/100 (bullish)
The headlines behind the move
45m agoThe FlyBULLISH 64Analyst
Exelixis price target raised to $60 from $53 at Morgan Stanley
58m agoThe Motley FoolBULLISH 63Earnings
Exelixis (EXEL) Q3 2026 Earnings Call Transcript
Cabozantinib sales grew 11% year over year as zanzalintinib advances toward FDA decisions.
2h agoThe FlyBULLISH 67Analyst
Exelixis price target raised to $76 from $55 at TD Cowen
5h agoGuruFocusBULLISH 64Earnings
Exelixis Inc (EXEL) (Q3 2026) Earnings Call Highlights: CABOMETYX Momentum and Zanzalintinib Pipeline Progress
5h agoThe FlyBULLISH 63Analyst
Exelixis Price Target Raised To 54 From 49 At Barclays
5h agoInvesting.com Analyst RatingsBULLISH 64Analyst
BMO raises Exelixis stock price target to $60 on OpEx outlook
BMO raises Exelixis stock price target to $60 on OpEx outlook
14h agoGuruFocusBULLISH 71Earnings
Exelixis (EXEL) Posts Strong Q3 2026 Results, Highlights Growth Pipeline
14h agoSeeking AlphaBULLISH 63Earnings
Exelixis outlines March 3, 2027 PDUFA for zanza while advancing Wave 2 pivotal plans
Exelixis Q3 2026 earnings: CABOMETYX growth, zanzalintinib pipeline milestones, and key 2027 catalysts.
15h agoSeeking AlphaNEUTRAL 50Earnings
Exelixis, Inc. (EXEL) Q3 2026 Earnings Call Transcript
Exelixis, Inc. (EXEL) Q3 2026 Earnings Call October 29, 2026 5:00 PM EDTCompany ParticipantsAndrew Peters - Senior Vice President of StrategyMichael...
Frequently asked questions
Why is EXEL stock up today?
EXELIXIS INC (EXEL) is up +8.14% in the latest session. Our newswire has captured 16 stories on EXEL across 7 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100). The most recent driver: "EXEL Maintained by Barclays -- Price Target Raised to $54.00" (GuruFocus).
Is EXEL a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of EXEL coverage reads 60/100 over 16 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More moves explained today
- Why is ATEC down today (-36.02%)
- Why is INTC down today (-28.29%)
- Why is RDDT down today (-28.16%)
- Why is CDNA up today (+23.45%)
- Why is RBLX down today (-19.54%)
- Why is CACC down today (-19.24%)
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on EXEL: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.